A Randomised, Controlled, Phase 3 Study of the Safety and Efficacy of Intracerebral Stem Cells (CTX0E03 DP) in Patients with Disability Following an Ischaemic Stroke

Administered By

Awarded By

Contributors

Start/End

  • December 18, 2017 - December 31, 2020